Pfizer Settles Its Subsidiary’s Kickback Allegations for Nearly $60 Million - Pfizer Inc. agreed to pay over $59,746,277 to ...

Dividend stocks have remained a focal point for investors, especially amid market volatility and the growing need for steady ...

Concord Wealth Partners boosted its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 253.0% during the fourth quarter, according to the company in its most recent filing with the ...

Dividend stocks have remained a focal point for investors, especially amid market volatility and the growing need for steady ...

Analysts on Wall Street project that Pfizer (PFE) will announce quarterly earnings of $0.48 per share in its forthcoming report, representing an increase of 380% year over year. Revenues are projected ...

Total proceeds of $530 million on $300 million original 2022 investment Proceeds strengthen balance sheet and provide added flexibility to pursue disciplined capital allocation strategy, including sig ...

Pfizer subsidiary Biohaven allegedly gave physicians speaker honoraria and meals at high-end restaurants to induce them to ...

Total proceeds of $530 million on $300 million original 2022 investment Proceeds strengthen balance sheet and provide added flexibility to pursue ...

Pfizer’s subsidiary Biohaven has agreed to a settlement nearing $60 million to resolve allegations of false claims related to improper physician remuneration. This settlement marks a pivotal moment in ...

Biohaven is accused of giving health care providers cash and lavish meals to get them to prescribe Nurtec ODT, a migraine ...

Attorney General Mike Hilgers announced Tuesday, Nebraska has joined the United States, 37 other states, and Puerto Rico to ...

World-recognized brand Pfizer has agreed to a nearly $60 million financial agreement to settle claims that a wholly-owned ...